Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleMeeting Proceedings

A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team

Allison Scott, Ren-Yo Forng, Mike Russ, Gilberto Dalmaso, Scott Hooper, Philip Villari, James Cannon, James Francis and Mike Dingle
PDA Journal of Pharmaceutical Science and Technology March 2021, 75 (2) 207-212; DOI: https://doi.org/10.5731/pdajpst.2020.012419
Allison Scott
1Azbil North America Research and Development: BioVigilant, 2005 W. Ruthrauff Rd. #151, Tucson, AZ 85705;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.scott.x4@biovigilant.azbil.com
Ren-Yo Forng
2Amgen, One Amgen Center Drive, Thousand Oaks, CA 91320-1799;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Russ
3Genentech/Roche, 1 Antibody Way, Oceanside, CA 92056;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilberto Dalmaso
4GDM Pharma Consulting, Via Ca’ Bianca, 2 Alpo di Villafranca di Verona, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Hooper
5Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Villari
6Merck & Co., Inc., 770 Sumneytown Pike, Mailstop WP78-210, West Point, PA 19486;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Cannon
7Mettler-Toledo Thornton, Inc., 900 Middlesex Turnpike, Building 8, Billerica, MA 01821;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Francis
8Micron View Limited, 1568 W. Bluff Rd., Orange, TX 77632; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Dingle
9TSI, Inc., 500 Cardigan Road, Shoreview, MN 55126.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    Center for Drug Evaluation and Research (CDER). Emerging Technology Program. FDA Web site, 2019. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/emerging-technology-program (accessed December 21, 2020).
  2. 2.↵
    1. Prasad A.,
    2. Scott A.,
    3. Manzer D.,
    4. Weber J.,
    5. Chen J.-P.,
    6. Lawson L.,
    7. Dingle M.,
    8. Noverini P.,
    9. Villari P.,
    10. Hooper S.
    Bio-Fluorescent Particle Counter-Based Real-Time Feedback and Control of Processing Conditions. Eur. Pharm. Rev. [Online] 2019. https://www.europeanpharmaceuticalreview.com/article/98107/biofluorescent-particle-counter-based-real-time-feedback-and-control-of-processing-conditions/ (accessed March 25, 2020).
  3. 3.↵
    1. Weber J.,
    2. Hauschild J.,
    3. Ijzerman-Boon P.,
    4. Forng R.-Y.,
    5. Horsch J.,
    6. Yan L.,
    7. Prasad A.,
    8. Henry R.,
    9. Claassen M.,
    10. Villari P.,
    11. Shereefa S.,
    12. Wyatt J.,
    13. Bolden J. S.,
    14. Pycke J.-T.,
    15. Dassu D.
    Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing. PDA J. Pharm. Sci. Technol. 2019, 73 (2), 121–134.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Montenegro-Alvarado J.-M.,
    2. Salvas J.,
    3. Weber J.,
    4. Mejías S.,
    5. Arroyo R.
    Pfizer Case Study: Rapid Microbial Methods for Manufacturing Recovery After Hurricane María. Pharm. Online [Online] 2018. https://www.pharmaceuticalonline.com/doc/pfizer-case-study-rapid-microbial-methods-for-manufacturing-recovery-after-hurricane-mar-a-0001 (accessed April 21, 2019).
  5. 5.↵
    Online Water Bioburden Analyzer Workgroup. A Better Approach to Pharmaceutical Water Testing – User Requirements for an Online Water Bioburden Analyzer. Pharm. Online [Online] 2018. https://www.pharmaceuticalonline.com/doc/a-better-approach-to-pharmaceutical-water-testing-user-requirements-for-an-online-water-bioburden-analyzer-0001 (accessed April 21, 2019).
  6. 6.↵
    1. Montenegro-Alvarado J.-M.
    Leveraging Rapid Microbiological Methodology in Forensic Evaluation to Identify Elusive Root Cause. Am. Pharm. Rev. [Online] 2018. https://www.americanpharmaceuticalreview.com/Featured-Articles/353500-Leveraging-Rapid-Microbiological-Methodology-in-Forensic-Evaluation-to-Identify-Elusive-Root-Cause/ (accessed April 21, 2019).
  7. 7.↵
    1. Anders H.-J.,
    2. Ayers F.,
    3. Fitch B.,
    4. Forng R.-Y.,
    5. Hooper S.,
    6. Luebke M.,
    7. Mateffy J.,
    8. Noverini P.,
    9. Termine B.,
    10. Yan L.,
    11. Weber J.
    Practical Application of Online Water Bioburden Analyzers in Pharmaceutical Manufacturing. Pharm. Online [Online]. 2017. https://www.pharmaceuticalonline.com/doc/practical-application-of-online-water-bioburden-analyzers-in-pharmaceutical-manufacturing-0001 (accessed April 21, 2019).
  8. 8.↵
    1. Russ M.
    Webinar—Changing a Paradigm: Implementing a Real Time Microbial Detection Analyzer in Pharmaceutical Water. Am. Pharm. Rev. [Online] 2019. https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&partnerref=ondemand&eventid=1905174&sessionid=1&key=18068A81C08D46A2024A3988BBB0B586&regTag=&sourcepage=register (accessed June 30, 2019).
  9. 9.↵
    1. Walter S.,
    2. Lipko B.,
    3. Termine B.
    Case Study: Retrofitting Two New High-Purity Water Systems. PharmTech [Online] 2017, 2017 (1), 18–26. http://www.pharmtech.com/case-study-retrofitting-two-new-high-purity-water-systems-0 (accessed April 22, 2019).
    OpenUrl
  10. 10.↵
    1. Sandle T.,
    2. Leavy C.,
    3. Jindal H.,
    4. Rhodes R.
    Application of Rapid Microbiological Methods for the Risk Assessment of Controlled Biopharmaceutical Environments. J. Appl. Microbiol. 2014, 116 (6), 1495–1505.
    OpenUrl
  11. 11.↵
    1. Prasad A.,
    2. Villari P.,
    3. Henry R.,
    4. Weber J.,
    5. Hauschild J.,
    6. Yan L.,
    7. Horsch J.,
    8. Shereefa S.,
    9. Rau J. E.,
    10. Milling A.,
    11. Bolden J. S.,
    12. Plourde L.,
    13. Claassen M.,
    14. Ijzerman-Boon P.,
    15. Forng R.-Y.,
    16. Portmann R.,
    17. Urwyler S.,
    18. Dassu D.
    Practical Applications of Bio-Fluorescent Particle Counting in Environmental Monitoring Investigations. PDA J. Pharm. Sci. Technol. 2020, 74 (3), 318–323.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 75 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 75, Issue 2
March/April 2021
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team
Allison Scott, Ren-Yo Forng, Mike Russ, Gilberto Dalmaso, Scott Hooper, Philip Villari, James Cannon, James Francis, Mike Dingle
PDA Journal of Pharmaceutical Science and Technology Mar 2021, 75 (2) 207-212; DOI: 10.5731/pdajpst.2020.012419

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Discussion on Bio-Fluorescent Particle Counters: Summary of the Process and Environmental Monitoring Methods Working Group Meeting with the FDA Emerging Technology Team
Allison Scott, Ren-Yo Forng, Mike Russ, Gilberto Dalmaso, Scott Hooper, Philip Villari, James Cannon, James Francis, Mike Dingle
PDA Journal of Pharmaceutical Science and Technology Mar 2021, 75 (2) 207-212; DOI: 10.5731/pdajpst.2020.012419
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • BFPC Background
    • Meeting Objectives
    • Submitted Questions and Responses
    • Conclusion
    • Conflict of Interest Declaration
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Commentary on "Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit"
  • Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool
  • Google Scholar

Similar Articles

Keywords

  • Bio-fluorescent particle counting (BFPC)
  • Rapid microbiological method (RMM)
  • FDA Emerging Technology Team (ETT)
  • Environmental monitoring
  • Auto-Fluorescence Unit (AFU)

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire